SONOVA (OTCMKTS:SONVY - Get Free Report) was upgraded by equities researchers at Sanford C. Bernstein from a "hold" rating to a "strong-buy" rating in a report issued on Friday,Zacks.com reports.
SONVY has been the topic of a number of other research reports. Kepler Capital Markets upgraded SONOVA from a "strong sell" rating to a "hold" rating in a report on Friday, June 6th. Barclays cut SONOVA from a "hold" rating to a "strong sell" rating in a report on Friday, June 20th. HSBC lowered SONOVA from a "buy" rating to a "hold" rating in a research note on Wednesday, May 21st. BNP Paribas lowered SONOVA from a "strong-buy" rating to a "strong sell" rating in a research note on Wednesday, June 11th. Finally, Hsbc Global Res cut SONOVA from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, May 21st. Four analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a strong buy rating to the company. According to MarketBeat.com, SONOVA presently has a consensus rating of "Hold".
View Our Latest Stock Analysis on SONVY
SONOVA Price Performance
OTCMKTS:SONVY traded up $1.19 during trading hours on Friday, hitting $58.30. The company's stock had a trading volume of 16,320 shares, compared to its average volume of 30,315. The stock has a fifty day moving average of $61.51 and a 200-day moving average of $62.40. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.96 and a current ratio of 1.27. SONOVA has a 52-week low of $52.83 and a 52-week high of $77.56.
About SONOVA
(
Get Free Report)
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Further Reading

Before you consider SONOVA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SONOVA wasn't on the list.
While SONOVA currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.